A siRNA screen targeting F-box proteins by Michele Pagano's group showed that downregulation of EMI1/FBXO5 in BRCA1-deficient triple-negative breast cancer (TNBC) cells conferred PARPi resistance (232). This evidence concerns the gene FBXO5 and triple-negative breast carcinoma.